We aimed to show that extraperitoneal cesarean delivery (EPCD) is more advantageous than trans peritoneal cesarean delivery (TPCD). Sixty cases analyzed either EPCD or TPCD were included in this study. Patients with suspected placental invasion anomalies (placenta accreta, increta or percreta), placenta previa, a history of midline uterine incision, multiple pregnancies, previous cesarean section, previous major abdominal surgery, delivery before 34 weeks of gestation or fetal macrosomia (estimated fetal weight >4500 g) were excluded. The endpoints were the duration of the operation, nausea and vomiting during the operation, postoperative nausea and vomiting, the number of an algesic medications, postoperative shoulder pain, postoperative gas/stool discharge time, complete blood count (CBC), urinary dysfunction, and neonatal outcomes. Results TPCD patients suffered significantly more intraoperative nausea (10% vs. 33.3%, p:0.03) and postoperative vomiting (0% vs. 13.3%, p: 0.04) compared to TPCD group. There was no significant difference in intraoperative vomiting and postoperative nausea rates between the two groups (p: 0,282). The duration of the operation was shorter in TPCD than EPCD groups (25,5 minutes vs. 28,7 minutes, p=0.01). After the operation, significantly fewer analgesic drugs were used in the EPCD than the TPCD groups (p: 0.01). The duration between defecation and operation was significantly shorter in the EPCD group compared to TPCD group (p: 0,042). Postoperative shoulder pain and flatulating time were similar between the two groups. There was no significant difference in urinary symptoms after six weeks of the operation between the two groups (p:0,690). No significant difference was found for neonatal outcomes between each groups. EPCD reduces postoperative pain, analgesic requirement, nausea, vomiting, and bowel dysfunction in cesarean patients without an increase in significant complications. [ABSTRACT FROM AUTHOR]